Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 246 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2021-10-08 | 2022-05-13 | 146901 |
APO-ONDANSETRON | 8MG | TABLET | Resolved | 2021-10-08 | 2022-02-28 | 146907 |
APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | TABLET | Resolved | 2021-10-08 | 2021-10-25 | 146910 |
APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-10-08 | 2021-12-22 | 146913 |
APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2021-10-15 | 2022-02-19 | 147289 |
APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2021-10-15 | 2021-11-29 | 147292 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2021-10-15 | 2022-01-31 | 147299 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2021-10-15 | 2022-01-31 | 147302 |
APO-ALENDRONATE/VITAMIN D3 | 2800UNIT 70MG | TABLET | Resolved | 2021-10-22 | 2021-10-29 | 147806 |
APO-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2021-10-22 | 2022-05-13 | 147809 |
APO-AMITRIPTYLINE | 75MG | TABLET | Resolved | 2021-10-22 | 2022-06-17 | 147812 |
APO-CANDESARTAN | 32MG | TABLET | Actual shortage | 2021-10-22 | 2021-10-22 | 147815 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2021-10-22 | 2021-12-09 | 147818 |
APO-PAROXETINE | 30MG | TABLET | Resolved | 2021-10-22 | 2021-10-29 | 147821 |
APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2021-10-22 | 2021-11-22 | 147826 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2021-10-29 | 2021-11-08 | 148491 |
APO-CETIRIZINE | 20MG | TABLET | Resolved | 2021-10-29 | 2021-12-06 | 148496 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2021-10-29 | 2022-02-28 | 148509 |
APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2021-10-29 | 2021-11-15 | 148539 |
APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2021-11-01 | 2021-11-29 | 148587 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Discontinued | 2018-09-07 | 2019-02-13 | 60426 |
APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Discontinued | 2022-09-06 | 2022-09-06 | 168648 |
APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Discontinued | 2018-12-20 | 2018-12-21 | 70250 |
APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |
APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
APO-NITRAZEPAM | 5MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1110 |
APO-NITRAZEPAM | 10MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1117 |